Systemic Treatments for Mesothelioma: Standard and Novel

Por Kindler, Hedy Lee
Publicado em 2008

Malignant Pleural Mesothelioma

Por Tsao, Anne S., Wistuba, Ignacio, Roth, Jack A., Kindler, Hedy Lee
Publicado no J Clin Oncol (2009)

Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium

Por Kindler, Hedy Lee, Wroblewski, Kristen, Wallace, James A., Hall, Michael J., Locker, Gershon, Nattam, Sreenivasa, Agamah, Edem, Stadler, Walter M., Vokes, Everett E.
Publicado no Invest New Drugs (2010)

A phase II study of sorafenib in malignant mesothelioma: results of CALGB 30307

Por Dubey, Sarita, Jänne, Pasi A., Krug, Lee, Pang, Herbert, Wang, Xiaofei, Heinze, Robin, Watt, Colleen, Crawford, Jeff, Kratzke, Robert, Vokes, Everett, Kindler, Hedy Lee
Publicado em 2010

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors

Por Hobday, Timothy J., Qin, Rui, Reidy-Lagunes, Diane, Moore, Malcolm J., Strosberg, Jonathan, Kaubisch, Andreas, Shah, Manisha, Kindler, Hedy Lee, Lenz, Heinz-Josef, Chen, Helen, Erlichman, Charles
Publicado no J Clin Oncol (2015)

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Por Kindler, Hedy Lee, Niedzwiecki, Donna, Hollis, Donna, Sutherland, Susan, Schrag, Deborah, Hurwitz, Herbert, Innocenti, Federico, Mulcahy, Mary Frances, O'Reilly, Eileen, Wozniak, Timothy F., Picus, Joel, Bhargava, Pankaj, Mayer, Robert J., Schilsky, Richard L., Goldberg, Richard M.
Publicado em 2010